Stifel analysts increased their price target on New Fortress Energy shares (NASDAQ:NFE) to $23.00, up from the previous $17.00, while reiterating a Buy rating on the stock. According to InvestingPro ...

Stifel raised the firm’s price target on New Fortress Energy (NFE) to $23 from $17 and keeps a Buy rating on the shares. The firm notes that on ...

Stifel CEO Ron Kruszewski discusses banks' M&A space and market valuation ahead of the new US administration's policy. Kruszewski speaks to Bloomberg's Lisa Abramowicz on the sidelines of the 2025 ...

CEO Ron Kruszewski and Yahoo Finance Executive Editor Brian Sozzi at the 2025 World Economic Forum in Davos, Switzerland, to talk about the macro issues impacting the investment banking firm, ...

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

Stifel Nicolaus analyst Brad Reback maintained a Buy rating on Workiva (WK – Research Report) today and set a price target of $130.00. The ...

Down 15-2 just a few minutes into their contest, it would take a monumental effort for the Wheeling Central Maroon Knights to ...

Equities researchers at Stifel Canada lifted their FY2024 earnings per share (EPS) estimates for shares of Kits Eyecare in a research note issued on Monday, January 20th. Stifel Canada analyst M.

On Tuesday, Canoo Inc (GOEV) stock saw a decline, ending the day at $0.37 which represents a decrease of $-0.98 or -72.59% from the prior close of $1.35. The stock opened at $0.39 and touched a low of ...

Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market ...

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...